Tag: bioresorbable medical material market size

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Bioresorbable Medical Material Market Become By 2030 Compared To 2026?

The scale of the biosimilar testing services market has seen substantial expansion recently. This market is projected to expand from $1.84 billion in 2025 to $2.08 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The upward trend observed historically can be linked to factors such as the broadening of biosimilar development initiatives, a rise in regulatory clearances for biosimilars, the expansion of biologics production, increased dependence on contract research organization (CRO) testing services, and advancements in analytical testing methodologies.

The biosimilar testing services market size is projected to experience substantial growth in the coming years. It is anticipated to expand to $3.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.8%. This projected increase is primarily driven by factors such as the increasing demand for cost-effective biologic alternatives, the global expansion of biosimilar markets, the growing complexity of biologic molecules, a heightened focus on comparability studies, and rising investments in biosimilar R&D. Throughout the forecast period, prominent trends are expected to include an increasing need for comprehensive analytical characterization, the rising adoption of advanced bioanalytical assays, a growing emphasis on regulatory-compliant testing services, the expansion of outsourced support for biosimilar development, and an enhanced focus on method validation and consistency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12219&type=smp

Which Growth Drivers Are Expected To Support The Bioresorbable Medical Material Market Forward?

The increasing incidence of autoimmune conditions is anticipated to fuel expansion within the biosimilar testing services market. Autoimmune diseases are characterized by the body’s immune system mistakenly attacking its own healthy tissues and cells, leading to inflammation and damage. The rising occurrence of these conditions stems from a growing demand for effective biologic therapies capable of managing chronic symptoms, reducing flare-ups, and enhancing long-term patient results. Biosimilar testing services are crucial for supporting autoimmune disease treatment by guaranteeing that biosimilars are safe, effective, and similar to original biologics, thereby making therapeutic options more affordable and accessible. For example, in February 2024, data from Arthritis Australia, an Australia-based non-profit organization, estimated that 562,378 Australians would be living with RA in 2025, constituting 14% of all arthritis cases that year. By 2040, this figure is forecast to grow by 33% to 748,721 people, representing an increase of 186,343 Australians with RA compared with 2025. Consequently, the rising prevalence of autoimmune diseases is a significant factor driving the growth of the biosimilar testing services market.

Which Segment Groups Define The Bioresorbable Medical Material Market Landscape?

The bioresorbable medical material market covered in this report is segmented –

1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA)

2) By Application: Drug Delivery, Orthopedics, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users

Subsegments:

1) By Polylactic Acid (PLA): Low Molecular Weight PLA, High Molecular Weight PLA, PLA Blends

2) By Polyglycolic Acid (PGA): Homopolymer PGA, Copolymer PGA

3) By Polysaccharides: Chitosan, Alginate, Hyaluronic Acid Derivatives

4) By Polycaprolactone (PCL): Standard PCL, PCL Copolymers

5) By Poly Lactic-Co-Glycolic Acid (PLGA): 50:50 PLGA, 75:25 PLGA

What Trends Are Driving Changes In The Bioresorbable Medical Material Market?

Leading companies in the biosimilar testing services market are focusing on expanding their facilities to introduce new technologies or capabilities that improve productivity and competitiveness. Facility expansion refers to the process of enlarging or upgrading existing physical spaces or infrastructure to accommodate increased operational needs or future growth. For instance, in October 2023, Tanvex BioPharma USA Inc., a US-based biotechnology company, introduced Tanvex CDMO, a modern contract development and manufacturing organization situated in San Diego. This organization offers comprehensive biologics development and manufacturing services, including cell line development, process optimization, analytical testing, and regulatory support. This new facility aims to speed up the advancement of biopharmaceutical products from concept to commercial scale, leveraging cutting-edge technologies and experienced teams to deliver innovative and life-changing biologics to patients worldwide.

Which Organizations Are Involved In The Bioresorbable Medical Material Market?

Major companies operating in the bioresorbable medical material market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.

Access The Complete Bioresorbable Medical Material Market Report:

https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report

Which Region Accounts For The Highest Share Of The Bioresorbable Medical Material Market?

North America was the largest region in the bioresorbable medical material market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Bioresorbable Medical Material Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12219&type=smp

Browse Through More Reports Similar to the Global Bioresorbable Medical Material Market 2026, By The Business Research Company

Medical Engineered Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

Core Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/core-materials-global-market-report

Biomaterials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The CRISPR-Based Diagnostics Market Grow Between 2026 And 2030?

The crispr-based diagnostics market size has seen rapid growth in recent years. It is anticipated to expand from $5.1 billion in 2025 to $6.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.8%. This historical increase can be attributed to the necessity for swift and accurate diagnostics, the limitations of conventional molecular tests, the heightened diagnostic demand driven by pandemics, breakthroughs in crispr detection methods, and the academic validation of crispr diagnostics.

The crispr-based diagnostics market is projected to experience substantial expansion in the coming years, reaching a valuation of $11.45 billion by 2030, reflecting a compound annual growth rate (CAGR) of 17.5%. This anticipated growth during the forecast period stems from factors such as the increasing prevalence of decentralized testing models, a heightened need for early disease identification, the broadening scope of point-of-care diagnostics, their seamless integration with digital health platforms, and their growing use in oncology and genetic screening. Significant trends during this period are expected to include the rising uptake of rapid molecular diagnostics, the continued development of point-of-care testing solutions, their expanded application in detecting infectious diseases, their integration with isothermal amplification techniques, and the emergence of personalized diagnostic applications.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Which Major Drivers Are Influencing The Expansion Of The CRISPR-Based Diagnostics Market?

The escalating occurrence of infectious diseases is anticipated to fuel the expansion of the CRISPR-based diagnostics market in the foreseeable future. Infectious diseases are defined as ailments stemming from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading directly or indirectly among individuals, through tainted surfaces, food, water, or vectors like insects. The frequency of these diseases is on the rise due to various factors including globalization, antibiotic resistance, climate change, urbanization, population growth, habitat destruction, and inadequate access to healthcare. CRISPR-based diagnostics enhance the combat against infectious diseases by providing rapid and accurate pathogen detection, thereby facilitating early diagnosis, timely intervention, and effective containment measures. For instance, in August 2024, data published by the UK Health Security Agency, a UK-based executive agency, revealed that England’s UKHSA reported 368 measles cases in 2023, signifying a nearly sevenfold increase from the 53 cases documented in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Consequently, the increasing incidence of infectious diseases is a primary driver for the CRISPR-based diagnostics market.

How Are Segments Identified Within The CRISPR-Based Diagnostics Market Segment Framework?

The crispr-based diagnostics market covered in this report is segmented –

1) By Product: Kits, Buffer Solutions, Software, Other Products

2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-Mediated Isothermal Amplification (LAMP), Other Techniques

3) By Disease: Infectious Diseases, Non-Infectious Diseases

4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits

2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers

3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software

4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes

Which Trends Are Shaping The CRISPR-Based Diagnostics Market?

Key players within the CRISPR-based diagnostics market are concentrating on forging strategic partnerships to boost the availability of fast and precise diagnostic solutions via CRISPR-based point-of-care tests. Such a partnership represents a sustained collaboration between multiple entities, pooling resources and specialized knowledge to achieve shared objectives and bolster their competitive standing. An illustrative example occurred in August 2023, when CrisprBits Private Limited, an India-based biotechnology firm, declared a strategic collaboration with Molbio Diagnostics, an India-based molecular diagnostics enterprise, for the development of CRISPR-based Point-of-Care Tests (POCTs). The essence of this partnership lies in crafting swift, accurate, and economical diagnostic instruments utilizing CRISPR technology for identifying pathogens and genetic markers. These POCTs are designed to broaden diagnostic access across various environments, notably in resource-constrained regions, concurrently guaranteeing prompt and precise disease identification. This alliance merges CrisprBits’ proficiency in CRISPR-based platforms with Molbio’s manufacturing and distribution infrastructure, aiming to introduce these diagnostic tests to a global audience.

Who Are The Companies Competing Within The CRISPR-Based Diagnostics Market?

Major companies operating in the crispr-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Epic Bio, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc., Caspr Biotech, GenScript, Twist Bioscience, Revvity Discovery Limited, Danaher Corporation, Scope Biosciences, CRISPR Diagnostics, Gene Editing Institute, Aptitude Medical Systems, Qiagen, Abingdon Health

Get The Full CRISPR-Based Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Which Region Is The Top Contributor To The CRISPR-Based Diagnostics Market By Share?

North America was the largest region in the CRISPR-based diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr-based diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized CRISPR-Based Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Browse Through More Reports Similar to the Global CRISPR-Based Diagnostics Market 2026, By The Business Research Company

Plant Breeding And Crispr Plants Market Report 2026

https://www.thebusinessresearchcompany.com/report/plant-breeding-and-crispr-plants-global-market-report

Crispr Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Crispr And Cas Gene Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Bioresorbable Medical Material Market Expected To Change From 2026 To 2030?

The market for bioresorbable medical materials has experienced robust expansion over recent years. Projections indicate its size will increase from $1.71 billion in 2025 to reach $1.88 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. Historically, this growth has been driven by factors such as the expanding application of biodegradable polymers in medical devices, a rise in surgical implant procedures, an increasing preference for minimally invasive treatments, progress in polymer chemistry, and the broadening of biomedical research endeavors.

The bioresorbable medical material market is projected for significant expansion in the coming years. This market is anticipated to reach $2.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this growth during the forecast period include the increasing adoption of regenerative medicine solutions, a rising demand for next-generation implant materials, the expansion of personalized medical devices, growing investments in tissue engineering technologies, and an intensified focus on reducing secondary surgeries. Key trends expected during the same period encompass the increasing adoption of bioresorbable polymer implants, a rising utilization of temporary medical implants, growing demand for advanced tissue engineering scaffolds, the expansion of drug-eluting bioresorbable devices, and an enhanced focus on controlled degradation materials.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report

Which Factors Are Influencing The Growth Of The Bioresorbable Medical Material Market?

The rising number of surgeries is projected to drive the expansion of the bioresorbable medical material market in the coming period. Surgical procedures refer to medical treatments that involve making an incision and employing tools to stop or repair disease in a living body. Bioresorbable polymers find application in molded medical equipment, particularly those utilized in neurology, orthopedics, and cosmetic surgery. These materials can be used to produce sutures, anchors, and screws. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, reported that aesthetic procedures reached nearly 35 million in 2023, with the cumulative number of surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Therefore, the increasing volume of surgeries is propelling the growth of the bioresorbable medical material market.

How Are Segments Identified Within The Bioresorbable Medical Material Market Segment Framework?

The bioresorbable medical material market covered in this report is segmented –

1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA)

2) By Application: Drug Delivery, Orthopedics, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users

Subsegments:

1) By Polylactic Acid (PLA): Low Molecular Weight PLA, High Molecular Weight PLA, PLA Blends

2) By Polyglycolic Acid (PGA): Homopolymer PGA, Copolymer PGA

3) By Polysaccharides: Chitosan, Alginate, Hyaluronic Acid Derivatives

4) By Polycaprolactone (PCL): Standard PCL, PCL Copolymers

5) By Poly Lactic-Co-Glycolic Acid (PLGA): 50:50 PLGA, 75:25 PLGA

Which Trends Are Influencing Demand In The Bioresorbable Medical Material Market?

Major companies in the bioresorbable medical material market are concentrating on developing innovative biomaterials for 3D printing applications to maintain their industry standing. Novel biomaterials are advanced, bioresorbable substances crafted to safely degrade within the body while supporting the creation of high-performance medical devices. As an illustration, in September 2023, Zeus Industrial Products, Inc., a US-based company known for advanced polymer solutions, introduced Absorv XSE, a next-generation tubing for bioresorbable vascular scaffolds. This product enhances the capabilities of vascular treatment devices by offering broad customization options across polymer types and sizes, allowing for tailored mechanical and absorption properties. Absorv XSE ensures improved wall-thickness consistency for reliable production and provides approximately 25% more usable scaffolds after laser cutting compared to previous versions.

Who Are The Companies Competing Within The Bioresorbable Medical Material Market?

Major companies operating in the bioresorbable medical material market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.

Get The Full Bioresorbable Medical Material Market Report:

https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report

Which Region Represents The Largest Share Of The Bioresorbable Medical Material Market?

North America was the largest region in the bioresorbable medical material market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Bioresorbable Medical Material Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report

Browse Through More Reports Similar to the Global Bioresorbable Medical Material Market 2026, By The Business Research Company

Biomaterials Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

Medical Engineered Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

Core Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/core-materials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Bioresorbable Medical Material Market Expected To Change From 2026 To 2030?

The market for bioresorbable medical materials has experienced robust expansion over recent years. Projections indicate its size will increase from $1.71 billion in 2025 to reach $1.88 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. Historically, this growth has been driven by factors such as the expanding application of biodegradable polymers in medical devices, a rise in surgical implant procedures, an increasing preference for minimally invasive treatments, progress in polymer chemistry, and the broadening of biomedical research endeavors.

The bioresorbable medical material market is projected for significant expansion in the coming years. This market is anticipated to reach $2.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this growth during the forecast period include the increasing adoption of regenerative medicine solutions, a rising demand for next-generation implant materials, the expansion of personalized medical devices, growing investments in tissue engineering technologies, and an intensified focus on reducing secondary surgeries. Key trends expected during the same period encompass the increasing adoption of bioresorbable polymer implants, a rising utilization of temporary medical implants, growing demand for advanced tissue engineering scaffolds, the expansion of drug-eluting bioresorbable devices, and an enhanced focus on controlled degradation materials.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report

Which Factors Are Influencing The Growth Of The Bioresorbable Medical Material Market?

The rising number of surgeries is projected to drive the expansion of the bioresorbable medical material market in the coming period. Surgical procedures refer to medical treatments that involve making an incision and employing tools to stop or repair disease in a living body. Bioresorbable polymers find application in molded medical equipment, particularly those utilized in neurology, orthopedics, and cosmetic surgery. These materials can be used to produce sutures, anchors, and screws. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, reported that aesthetic procedures reached nearly 35 million in 2023, with the cumulative number of surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Therefore, the increasing volume of surgeries is propelling the growth of the bioresorbable medical material market.

How Are Segments Identified Within The Bioresorbable Medical Material Market Segment Framework?

The bioresorbable medical material market covered in this report is segmented –

1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA)

2) By Application: Drug Delivery, Orthopedics, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users

Subsegments:

1) By Polylactic Acid (PLA): Low Molecular Weight PLA, High Molecular Weight PLA, PLA Blends

2) By Polyglycolic Acid (PGA): Homopolymer PGA, Copolymer PGA

3) By Polysaccharides: Chitosan, Alginate, Hyaluronic Acid Derivatives

4) By Polycaprolactone (PCL): Standard PCL, PCL Copolymers

5) By Poly Lactic-Co-Glycolic Acid (PLGA): 50:50 PLGA, 75:25 PLGA

Which Trends Are Influencing Demand In The Bioresorbable Medical Material Market?

Major companies in the bioresorbable medical material market are concentrating on developing innovative biomaterials for 3D printing applications to maintain their industry standing. Novel biomaterials are advanced, bioresorbable substances crafted to safely degrade within the body while supporting the creation of high-performance medical devices. As an illustration, in September 2023, Zeus Industrial Products, Inc., a US-based company known for advanced polymer solutions, introduced Absorv XSE, a next-generation tubing for bioresorbable vascular scaffolds. This product enhances the capabilities of vascular treatment devices by offering broad customization options across polymer types and sizes, allowing for tailored mechanical and absorption properties. Absorv XSE ensures improved wall-thickness consistency for reliable production and provides approximately 25% more usable scaffolds after laser cutting compared to previous versions.

Who Are The Companies Competing Within The Bioresorbable Medical Material Market?

Major companies operating in the bioresorbable medical material market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.

Get The Full Bioresorbable Medical Material Market Report:

https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report

Which Region Represents The Largest Share Of The Bioresorbable Medical Material Market?

North America was the largest region in the bioresorbable medical material market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Bioresorbable Medical Material Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report

Browse Through More Reports Similar to the Global Bioresorbable Medical Material Market 2026, By The Business Research Company

Biomaterials Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

Medical Engineered Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

Core Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/core-materials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Bioresorbable Medical Material Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The bioresorbable medical material market has seen substantial growth in recent years. This market is expected to increase from $1.71 billion in 2025 to $1.88 billion in 2026, registering a compound annual growth rate (CAGR) of 9.9%. Several factors contributed to its historical expansion, including the increasing application of biodegradable polymers in medical devices, a rise in surgical implant procedures, growing preference for minimally invasive treatments, progress in polymer chemistry, and the broadened scope of biomedical research activities.

The bioresorbable medical material market is projected to experience substantial expansion in the next few years. It is forecast to reach $2.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This growth during the forecast period can be attributed to the increasing uptake of regenerative medicine solutions, a heightened demand for next-generation implant materials, the broadening availability of personalized medical devices, growing investments in tissue engineering technologies, and an increasing focus on reducing secondary surgical procedures. Major trends anticipated in the upcoming period include the wider adoption of bioresorbable polymer implants, a rising utilization of temporary medical implants, a surging requirement for advanced tissue engineering scaffolds, the expansion of drug-eluting bioresorbable devices, and an enhanced emphasis on materials engineered for controlled degradation.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12219&type=smp

What Drivers Are Influencing The Bioresorbable Medical Material Market?

The increasing volume of surgical procedures is projected to stimulate the expansion of the bioresorbable medical material market moving forward. Surgical interventions are medical treatments that involve making an incision and employing instruments to halt or mend diseases within a living organism. Bioresorbable polymers are incorporated into molded medical apparatus, especially those utilized in neurology, orthopedics, and aesthetic surgery. Bioresorbable materials serve as components for sutures, anchors, and screws. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, reported that aesthetic procedures reached nearly 35 million in 2023, with the overall number of surgical and non-surgical procedures growing by 3.4% to 34.9 million. Consequently, the rising occurrence of surgeries is fueling the development of the bioresorbable medical material market.

What Major Segment Divisions Exist Within The Bioresorbable Medical Material Market?

The bioresorbable medical material market covered in this report is segmented –

1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA)

2) By Application: Drug Delivery, Orthopedics, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users

Subsegments:

1) By Polylactic Acid (PLA): Low Molecular Weight PLA, High Molecular Weight PLA, PLA Blends

2) By Polyglycolic Acid (PGA): Homopolymer PGA, Copolymer PGA

3) By Polysaccharides: Chitosan, Alginate, Hyaluronic Acid Derivatives

4) By Polycaprolactone (PCL): Standard PCL, PCL Copolymers

5) By Poly Lactic-Co-Glycolic Acid (PLGA): 50:50 PLGA, 75:25 PLGA

What Industry Trends Are Redefining The Bioresorbable Medical Material Market?

Companies operating in the bioresorbable medical material market are primarily focused on developing novel biomaterials for 3D printing applications to sustain their industry position. These novel biomaterials are advanced, bioresorbable substances engineered to safely degrade inside the body while simultaneously supporting the creation of high-performance medical devices. For instance, in September 2023, Zeus Industrial Products, Inc., a US-based company specializing in advanced polymer solutions, launched Absorv XSE, next-generation tubing designed for bioresorbable vascular scaffolds. This product enhances the capabilities of vascular treatment devices by offering extensive customization across various polymer types and sizes, enabling tailored mechanical and absorption properties. Absorv XSE ensures improved wall-thickness uniformity, leading to consistent production, and provides approximately 25% more usable scaffolds after laser cutting compared to earlier versions.

Which Companies Are Leading Innovation In The Bioresorbable Medical Material Market?

Major companies operating in the bioresorbable medical material market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.

Read the full bioresorbable medical material market report here:

https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Bioresorbable Medical Material Market?

North America was the largest region in the bioresorbable medical material market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bioresorbable Medical Material Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12219&type=smp

Browse Through More Reports Similar to the Global Bioresorbable Medical Material Market 2026, By The Business Research Company

Medical Engineered Materials Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

Core Materials Global Market Report

https://www.thebusinessresearchcompany.com/report/core-materials-global-market-report

Biomaterials Global Market Report

https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model